Galantamine Hydrobromide (Reminyl®)

Supports proper nicotinic receptor activity

Reminyl® is a brand name for galantamine, which is a phytonutrient extracted from the common snowdrop plant.

It’s been shown to act as an acetylcholinesterase inhibitor and block the age-related breakdown of the neurotransmitter acetylcholine (ACh). This has important implications for those concerned with Alzheimer’s since galantamine can improve ACh levels and it is the principal neurotransmitter ‘lost’ in the disease. Accordingly, this has become the principle use and focus for galantamine around the world.

In addition, galantamine also supports proper nicotinic receptor activity, an effect known to influence memory function. It may be this action that has led to it being utilised for other generalised states of vascular dementia. 

Other off-label uses for galantamine have been detailed for the alleviation of depression. There is also anecdotal evidence that points to galantamine having a potential role in weight loss, due to its appetite suppressant effects.

This product features in the
following categories

Anti Aging Treatments Specialist Products

This product has the
following ingredients

Galantamine Hydrobromide

This product is associated with the following health conditions

Alzheimer’s Disease Parkinson’s disease Senile dementia

Product Description

This leaflet contains important information. Please read it carefully before use. If you are a carer and will be giving Reminyl to the person you look after, it is also important that you read this leaflet on their behalf. If you have any questions or concerns after reading the leaflet, speak to your doctor or pharmacist.



The name of this medicine is Reminyl®, it contains the active ingredient galantamine hydrobromide. Reminyl® comes in 3 different strengths of tablets, as indicated below:

  • The off-white tablets contain 4 mg galantamine and are marked G4.
  • The pink tablets contain 8 mg galantamine and are marked G8.
  • The orange-brown tablets contain 12 mg galantamine and are marked G12.


The tablets also contain the inactive ingredients; colloidal anhydrous silica, crospovidone, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, propylene glycol, talc and titanium dioxide (E111).


The tablets contain the following colouring agents: 4mg tablets: yellow ferric oxide (E172); 8 mg tablets: red ferric oxide (E172); 12 mg tablets: red ferric oxide (E172) and orange yellow S aluminium lake (E110). Note: The coloring E110 in the 12mg tablets can cause an allergic reaction, like asthma, in some people. An allergic reaction to E110 is more likely in people who are allergic to aspirin (acetylsalicylic acid). Speak to your doctor for advice before taking any tablets.



Reminyl® is used to treat the symptoms of mild to moderately severe dementia of the Alzheimer type, a disease that alters brain function. The symptoms include progressive memory loss, increasing confusion and behavioral changes. As a result, sufferers find it becomes more and more difficult to carry out their normal daily activities. Symptoms of dementia of the A1zheimer type are believed to be related to a lack of acetylcholine, a substance responsible for sending messages between brain cells. Reminyl® works by increasing the amount of acetylcholine in the brain and so improves the symptoms of the disease.



Reminyl® should not be taken by people who have had an allergic reaction to galantamine or to any of the other ingredients. Check the ingredients by reading the section above called ‘What is Reminyl®’. An allergic reaction may be recognised as a rash, itching, swollen face or lips, or shortness of breath- By people who have either severe liver or severe kidney disease. By people who have significant, combined liver and kidney problems. Speak to your doctor if you suffer from these problems or have suffered from them in the past.



Medicines are not always suitable for everyone. Do you have any of the following conditions? Have you suffered from these in the past? Liver or kidney problems; heart disorders; stomach ulcer or duodenal ulcer; acute abdominal pain; epilepsy; respiratory diseases that affect breathing (like asthma); A recent operation on the gut or bladder or difficulties in passing urine; galactose intolerance, lactase deficiency or glucose-galactose malabsorption. As Reminyl® contains lactose it may not be suitable for you.


If the answer to any of these questions is ‘Yes’, speak to your doctor for advice before any Reminyl® is taken. Your doctor will decide whether this medicine is suitable for you. Your doctor may adjust the amount of medicine that you take.


If you are pregnant, trying to become pregnant or breast-feeding, do not take any Reminyl® before speaking to your doctor for advice. If you need to have a general anesthetic for an operation, tell the doctor that Reminyl® is being taken.


Reminyl® is not recommended for children. Reminyl® is not recommended for driving or operating machinery (Reminyl®, as well as the disease itself, can affect the ability to drive or operate machinery. Please discuss this with your doctor).



Always tell your doctor; nurse or pharmacist if any other medicines are being taken because taking some medicines together can be harmful.


Reminyl® should not be taken with other medicines that act the same way. If medicines for diarrhea, Parkinson’s disease or asthma are taken, check with your doctor to see if these affect Reminyl. Tell your doctor if drugs for certain heart disorders or high blood pressure, (e.g. digoxin or the so-called beta-blockers) are being taken.


Your doctor may prescribe a smaller dose of Reminyl® if certain drugs are being taken at the same time, (for example certain antidepressants (such as paroxetine, fluoxetine or fluvoxamine), quinidine (used for heart rhythm problems), ketoconazole (an antifungal) or ritonavir, (a treatment for HIV).

If you are not sure, speak to your doctor or pharmacist for advice.



Reminyl® should be taken by mouth. It should be taken twice a day, preferably with morning and evening meals.


Reminyl® is usually started at a low dose. Your doctor may then slowly increase the amount of Reminyl® that you take to find the most suitable dose for you.


Treatment with Reminyl® is usually started at a dose of 4 mg taken twice daily. This dose will be taken for at least four weeks. Your doctor will then increase the dose to 8 mg taken twice daily. This dose will be taken for at least 4 weeks. Your doctor may decide to increase your dose again.


What if a dose of Reminyl® is forgotten?

If a dose is missed, the next dose should be taken as usual. Then continue as before. If more than one dose has been missed, contact your doctor for advice. Do not take 2 doses at the same time to make up for a missed dose.



If too much Reminyl® has been taken, contact a doctor or hospital straightaway. Take any remaining tablets and the packaging with you.



If undesired effects such as nausea and vomiting occur, they are mainly experienced early in the treatment, or when the dose is increased. They tend to disappear gradually as the body gets used to the treatment and generally will not last for more than a few days. If you are experiencing these effects your doctor may recommend that you drink more liquids and if necessary, they may prescribe medicine to stop you being sick.


Other possible side effects include: abdominal pain, diarrhea, indigestion, decreased appetite and weight loss. Also, headache, dizziness, tiredness, sleepiness or sleeplessness and confusion might be experienced as well as a runny or blocked nose, a urinary tract infection and falling, sometimes resulting in injury.


In very rare cases trembling has occurred. A slow heartbeat or fainting has also been reported. Should such symptoms be experienced, contact a doctor as medical assistance might be necessary.


Do not be alarmed by this list of possible side effects. You may not have any of them. Tell your doctor or pharmacist if you are worried or think that Reminyl® is causing you any problem.



There are no special storage instructions for Reminyl® tablets. Medicines can be kept for a limited period only. Therefore, do not use Reminyl® after the date printed on the packaging. Always return any leftover medicines to your pharmacist.




Looking for another product?